HEALTHCBS NEWS
Doctors prescribing weight loss drug not yet approved by FDA, CBS News investigation finds
The weight loss drug retatrutide, still in clinical trials and not FDA approved, is being prescribed by doctors despite potential serious side effects, according to a CBS News investigation. The drug has been described as 'Ozempic on steroids' and is being offered to patients before regulatory approval.
Related Signal
Adjacent reporting
- STAT+: Lilly’s ‘triple-G’ drug leads to bariatric-surgery levels of weight loss in trial
- New Weight Loss Drug Retatrutide Delivers Stunning Results
- Eli Lilly says next-generation weight loss drug clears crucial obesity trial
- How an experimental weight-loss drug is being openly promoted by physicians
- STAT+: Lilly shares safety, tolerability data on its next-gen obesity drug
- New obesity drug from Lilly delivers major weight loss